Su1060 Racial/Ethnic Differences in Inflammatory Bowel Disease Phenotypes At a Tertiary Care Academic Medical Center

Mannino, Christie; Malin, Jessica; Conn, Andrew; Judge, Thomas A.; Wang, Yize R.

doi:10.1016/s0016-5085(13)61428-6

Cited by 2 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The following countries reported at least one study: Costa Rica, 15 Argentina, 16 17 Colombia, 18 19 Chile, [20][21][22][23] Cuba, [24][25][26] Mexico, [27][28][29] Puerto Rico, [30][31][32] Uruguay, [33][34][35] Peru, [36][37][38][39][40] and Brazil. [41][42][43][44][45][46][47][48][49][50][51][52][53][54][55][56][57][58][59][60] Seven US Hispanic studies [61][62][63][64][65][66][67] were included. The US-based studies were gathered from a p...…”

Section: Resultsmentioning

confidence: 99%

“…The following countries reported at least one study: Costa Rica,15 Argentina,16 17 Colombia,18 19 Chile,20-23 Cuba,24-26 Mexico,27-29 Puerto Rico,30-32 Uruguay,33-35 Peru,36-40 and Brazil 41-60. Seven US Hispanic studies61-67 were included. The US-based studies were gathered from a previously published systematic review11 with an updated surveillance search up to March 2019 which did not yield any new relevant studies.…”

Section: Resultsmentioning

confidence: 99%

“…Studies that evaluated CD within the USA were also found to have high levels of heterogeneity (I 2 =92.5%). Based on the previous selection/exclusion criteria, five studies were removed from the analysis 61 62 64-66. With this exclusion, heterogeneity in US Hispanics with CD was controlled (I 2 =0.00%).…”

Section: Secondary Outcomesmentioning

confidence: 99%

See 2 more Smart Citations

Latin Americans and US Hispanics show Differences in IBD Phenotype: A Systematic Review with Meta-Analysis

Avalos¹,

Satiya

Contreras

et al. 2022

Journal of Investigative Medicine

View full text Add to dashboard Cite

Latin America has experienced a rise in the prevalence and incidence of inflammatory bowel disease (IBD). Differences in IBD phenotype between Hispanics in Latin America and those in the USA have not been described. We conducted a systematic review with meta-analysis of population-based and cohort studies comparing the phenotype of ulcerative colitis (UC) and Crohn’s disease (CD) in Latin Americans and US Hispanics. A systematic search was conducted up to March 2019 using MEDLINE, EMBASE and Google Scholar. Inclusion criterion includes studies describing IBD phenotype in Latin Americans or in US Hispanics. Exclusion criterion includes prevalence or incidence studies not describing phenotype. A random effects model was chosen “a priori” for analysis of pooled proportions. A total of 46 studies were included from Latin America and 7 studies from the USA. The predominant IBD subtype in Latin America was UC with a more balanced UC:CD ratio noted in Puerto Rico (0.53) and Brazil (0.56). UC-related extensive colitis was more common in US Hispanics (0.64) than in Latin Americans (0.38), p<0.001. CD phenotype was similar between US Hispanics and Latin Americans. UC is the predominant IBD subtype in Latin America, with the exception of Puerto Rico and Brazil which demonstrate a more balanced UC:CD ratio. In UC, extensive colitis was more frequently seen in US Hispanics than in Latin Americans. CD phenotype was similar in both US Hispanics and Latin Americans.

show abstract